NYSE:IVC
Delisted
Invacare Corporation Stock News
$0.660
+0 (+0%)
At Close: Apr 28, 2023
Invacare files for bankruptcy, but expects to keep making and delivering home-care products
09:31am, Wednesday, 01'st Feb 2023
Invacare Corp. IVC, -2.25% said Wednesday it and two of its U.S.-based subsidiaries have filed for bankruptcy, as it implements a refinancing aimed at reducing net debt by about 65%. The stock is curr
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
06:38pm, Monday, 19'th Dec 2022 Benzinga
Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Axcella H
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket
12:38pm, Friday, 25'th Nov 2022 Benzinga
Gainers
VEON Ltd. (NASDAQ: VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion).
Cosmos Hol
Azurite Trims Invacare Stake after Inadvertently Passing 10% Ownership Trigger
07:16pm, Wednesday, 23'rd Nov 2022
Fintel reports that Rosen Steven H and his Azurite Management LLC filed a 13D/A form with the SEC disclosing ownership of 3,665,233 shares of Invacare Corporation (IVC cnx.cmd.push(function() {var v
Invacare Corporation (IVC) Q3 2022 Earnings Call Transcript
09:21am, Saturday, 12'th Nov 2022
Invacare Corporation (NYSE:IVC ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Lois Lee - Director of Treasury, Investor Relations and Corporate Communications Geof
Invacare (IVC) Reports Q3 Loss, Misses Revenue Estimates
11:45pm, Monday, 07'th Nov 2022 Zacks Investment Research
Invacare (IVC) delivered earnings and revenue surprises of -45.95% and 13.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Invacare (IVC) Reports Q3 Loss, Misses Revenue Estimates
08:19pm, Monday, 07'th Nov 2022
Invacare (IVC) delivered earnings and revenue surprises of -45.95% and 13.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
09:56am, Wednesday, 24'th Aug 2022 Benzinga
Gainers
Windtree Therapeutics, Inc. (NASDAQ: WINT) shares jumped 55.2% to close at $0.70 on Tuesday after the company announced it has entered into a global licensing agreement for the development an
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session
04:14pm, Tuesday, 23'rd Aug 2022 Benzinga
Gainers
Windtree Therapeutics, Inc. (NASDAQ: WINT) shares surged 60.5% to $0.7238 after the company announced it has entered into a global licensing agreement for the development and commercializatio
Invacare Corporation's (IVC) CEO Matt Monaghan on Q2 2022 Results - Earnings Call Transcript
10:25am, Tuesday, 09'th Aug 2022
Invacare Corporation (NYSE:IVC ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Lois Lee - Director of Treasury, Investor Relations and Corporate Communications Matt M
Invacare (IVC) Reports Q2 Loss, Lags Revenue Estimates
11:25pm, Monday, 08'th Aug 2022 Zacks Investment Research
Invacare (IVC) delivered earnings and revenue surprises of -20.45% and 11.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Invacare (IVC) Reports Q2 Loss, Lags Revenue Estimates
09:04pm, Monday, 08'th Aug 2022
Invacare (IVC) delivered earnings and revenue surprises of -20.45% and 11.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
West Pharmaceutical Services (WST) Q2 Earnings and Revenues Surpass Estimates
11:15am, Thursday, 28'th Jul 2022 Zacks Investment Research
West Pharmaceutical (WST) delivered earnings and revenue surprises of 12.79% and 2.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More
11:41am, Tuesday, 28'th Jun 2022 Benzinga
U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concer
Insiders Buy Around $20M Of 2 Penny Stocks
12:18pm, Wednesday, 08'th Jun 2022 Benzinga
US stocks closed higher on Tuesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's p